M. L. Vegna

3.3k total citations
20 papers, 1.2k citations indexed

About

M. L. Vegna is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, M. L. Vegna has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in M. L. Vegna's work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). M. L. Vegna is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). M. L. Vegna collaborates with scholars based in Italy, France and Netherlands. M. L. Vegna's co-authors include Franco Mandelli, Giuseppe Avvisati, Sergio Amadori, M Tribalto, Franco Dammacco, Vito Michele Lauta, Angela Gernone, Maria Teresa Petrucci, Alessandro Pileri and Filippo Marmont and has published in prestigious journals such as New England Journal of Medicine, Blood and European Journal of Cancer.

In The Last Decade

M. L. Vegna

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. L. Vegna Italy	14	765	517	296	218	186	20	1.2k
Anne Marie Stoppa France	18	844 1.1×	555 1.1×	322 1.1×	196 0.9×	124 0.7×	43	1.2k
Delvyn C. Case United States	17	666 0.9×	306 0.6×	538 1.8×	404 1.9×	511 2.7×	42	1.4k
Ángel León Spain	14	1.1k 1.4×	687 1.3×	405 1.4×	253 1.2×	328 1.8×	21	1.6k
WJ Miller United States	12	1.0k 1.3×	272 0.5×	242 0.8×	363 1.7×	137 0.7×	19	1.4k
Éliane Duchayne France	18	701 0.9×	312 0.6×	241 0.8×	470 2.2×	356 1.9×	38	1.2k
Emma Das‐Gupta United Kingdom	18	725 0.9×	425 0.8×	261 0.9×	180 0.8×	212 1.1×	34	1.2k
Anand P. Jillella United States	15	485 0.6×	314 0.6×	280 0.9×	222 1.0×	107 0.6×	55	866
Don Milligan United Kingdom	13	637 0.8×	231 0.4×	327 1.1×	384 1.8×	369 2.0×	26	1.1k
Susan McKenzie United States	14	766 1.0×	367 0.7×	342 1.2×	247 1.1×	158 0.8×	19	1.2k
Ana Balanzategui Spain	25	491 0.6×	440 0.9×	459 1.6×	492 2.3×	539 2.9×	70	1.5k

Countries citing papers authored by M. L. Vegna

Since Specialization

Citations

This map shows the geographic impact of M. L. Vegna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Vegna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Vegna more than expected).

Fields of papers citing papers by M. L. Vegna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Vegna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Vegna. The network helps show where M. L. Vegna may publish in the future.

Co-authorship network of co-authors of M. L. Vegna

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Vegna. A scholar is included among the top collaborators of M. L. Vegna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Vegna. M. L. Vegna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mauro, Francesca Romana, Pier Luigi Zinzani, Francesco Zaja, et al.. (2003). Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.. PubMed. 88(12). 1348–57. 3 indexed citations

Bona, Eros Di, Giuseppe Avvisati, Giancarlo Castaman, et al.. (2000). Early haemorrhagic morbidity and mortality during remission induction with or without all‐trans retinoic acid in acute promyelocytic leukaemia. British Journal of Haematology. 108(4). 689–695. 104 indexed citations

Witte, T. de, Stefan Suciu, Franco Mandelli, et al.. (1999). Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Journal of Cancer. 35(10). 1440–1447. 7 indexed citations

Majolino, Ignazio, Marco Vignetti, Giovanna Meloni, et al.. (1999). Autologous transplantation in multiple myeloma : a GITMO retrospective analysis on 290 patients. 84(9). 844–852. 24 indexed citations

Pagano, Livio, Luciana Annino, Antonella Ferrari, et al.. (1998). Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukaemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. British Journal of Haematology. 100(4). 669–676. 13 indexed citations

Cordone, Iole, Serena Masi, Francesca Romana Mauro, et al.. (1998). p53 Expression in B-Cell Chronic Lymphocytic Leukemia: A Marker of Disease Progression and Poor Prognosis. Blood. 91(11). 4342–4349. 149 indexed citations

Guglielmi, Cesare, Maria Paola Martelli, Daniela Diverio, et al.. (1998). Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. British Journal of Haematology. 102(4). 1035–1041. 143 indexed citations

Witte, Théo de, Stefan Suciu, Roel Willemze, et al.. (1998). The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. British Journal of Haematology. 102(5). 1344–1353. 72 indexed citations

Venuta, Federico, Erino Angelo Rendina, Edoardo Pescarmona, et al.. (1997). Multimodality Treatment of Thymoma: A Prospective Study. The Annals of Thoracic Surgery. 64(6). 1585–1592. 95 indexed citations

10.

Suciu, Stefan, T.J.M. de Witte, Franco Mandelli, et al.. (1996). Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.. PubMed. 17(6). 993–1001. 55 indexed citations

11.

Spadea, Antonio, Maria Concetta Petti, Paola Fazi, et al.. (1993). Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.. PubMed. 7(4). 549–52. 48 indexed citations

12.

Castoldi, Gianluigi, Vincenzo Liso, S. Fenu, M. L. Vegna, & Franco Mandelli. (1993). Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience. Annals of Hematology. 66(4). 171–174. 20 indexed citations

13.

Vegna, M. L., Sergio Amadori, Antonio Spadea, et al.. (1992). A randomized study of the efficacy of postconsolidation therapy in adult acute nonly mphocytic leukemia: a report of the Italian Cooperative Group GIMEMA. Annals of Hematology. 64(4). 166–172. 13 indexed citations

14.

Papa, Giuseppe Francesco Sferrazza, S Tura, Franco Mandelli, et al.. (1991). Is interferon alpha in cutaneous T‐cell lymphoma a treatment of choice?. British Journal of Haematology. 79(s1). 48–51. 42 indexed citations

15.

Avvisati, Giuseppe, Franco Mandelli, Maria Concetta Petti, et al.. (1990). Idarubicin (4‐demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA. European Journal Of Haematology. 44(4). 257–260. 60 indexed citations

16.

Petti, Maria Concetta, G Broccia, Francesco Paolo Caronia, et al.. (1990). Therapy of Acute Myelogenous Leukemia in Adults. Hämatologie und Bluttransfusion. 33. 249–253. 2 indexed citations

17.

Vegna, M. L., Giuseppe Francesco Sferrazza Papa, Francesco Pisani, et al.. (1990). Interferon alpha‐2a in cutaneous T‐cell lymphoma. European Journal Of Haematology. 45(S52). 32–35. 24 indexed citations

18.

Mandelli, Franco, Giuseppe Avvisati, Sergio Amadori, et al.. (1990). Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy. New England Journal of Medicine. 322(20). 1430–1434. 296 indexed citations

19.

Amadori, Sergio, Adriana Ceci, A Comelli, et al.. (1990). Therapy of Childhood Acute Myelogenous Leukemia: An Update of the AIEOP/LAM 8204 Study. Hämatologie und Bluttransfusion. 33. 222–225. 3 indexed citations

20.

Petti, M C, Maria Antonietta Aloe Spiriti, Angelo Michele Carella, et al.. (1990). Intensification in post-remission treatment of adult acute non lymphocytic leukemia.. PubMed. 74(3). 267–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact